Plano, Texas/Belfast, Northern Ireland – August 21, 2024, 08:41 ET – B-Secur, a leader in advanced biosensing technology, and FIRMINIQ, a software product development company specializing in connected health, are proud to announce a strategic partnership aimed at transforming cardiovascular health management globally.
By integrating B-Secur’s enhanced ECG software with FIRMINIQ’s cutting-edge connected health solutions, this collaboration will empower healthcare providers in the effective prevention, diagnosis, and management of heart-related chronic diseases. Additionally, B-Secur’s technology can extend these ECG-based insights to wearables and sports tech, broadening the scope of heart health monitoring to include fitness and wellness applications.
Cardiac health is the largest cost burden on the healthcare system and is projected to increase from 2.7% of the U.S. GDP to 4.6% over the next 30 years, according to a recent study*. B-Secur and FIRMINIQ’s joint offering looks to address this growing challenge by delivering solutions that not only improve patient outcomes but also drive significant cost efficiencies. By enabling earlier detection and more personalized care, these innovations have the potential to reduce the economic strain on healthcare systems.
“Teaming up with B-Secur allows us to push the boundaries of what’s possible in connected health,” said Deepesh Goel, CEO of FIRMINIQ. “Our combined expertise will enable healthcare providers to access critical real-time data, leading to more effective prevention, diagnosis, and management of cardiovascular diseases. We believe this partnership will set a new standard in patient-centric care, driving innovation that not only improves lives but also helps healthcare organizations operate more efficiently and effectively.”
“Our new alliance with FIRMINIQ represents a significant leap forward in how we approach cardiovascular health management,” said Brian Pitstick, CCO of B-Secur. “By combining our ECG technology with FIRMINIQ’s innovative connected health solutions, we are enhancing the accuracy of heart disease detection while enabling healthcare providers to deliver more efficient, personalized, and proactive care. We are deeply committed to using cutting-edge technology to improve patient outcomes and reduce the overall burden on healthcare systems worldwide.”
* Dhruv S. Kazi, Mitchell S.V. Elkind, Anne Deutsch, et al. Forecasting the Economic Burden of Cardiovascular Disease and Stroke in the United States Through 2050: A Presidential Advisory from the American Heart Association, Circulation (2024), DOI – 10.1161/CIR.0000000000001258, https://www.ahajournals.org/doi/10.1161/CIR.0000000000001258